Related Experiment Video
Updated: Feb 12, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Downregulated eosinophil activity in ulcerative colitis with concomitant primary sclerosing cholangitis
Maria Lampinen1, Annika Fredricsson1, Johan Vessby1
1Department of Medical Sciences, Gastroenterology Research Group, University Hospital, Uppsala, Sweden.
Eosinophil activation differs between ulcerative colitis (UC) and UC with primary sclerosing cholangitis (PSC). This immune cell phenotype may depend on the colonic cytokine profile, offering insights into PSC-UC pathogenesis.
Area of Science:
- Gastroenterology
- Immunology
- Hepatology
Background:
- Primary sclerosing cholangitis (PSC) is a chronic bile duct inflammation linked to ulcerative colitis (UC).
- The relationship between intestinal and bile duct inflammation in PSC-UC remains unclear.
- The role of intestinal immune cells, like eosinophils, in PSC pathogenesis requires further investigation.
Purpose of the Study:
- To investigate differences in intestinal eosinophil accumulation and activation between UC and PSC-UC.
- To explore the influence of the intestinal cytokine/chemokine profile on these eosinophil characteristics.
Main Methods:
- Analysis of eosinophils from peripheral blood and colon using flow cytometry.
- Assessment of intestinal inflammatory mediators via multiplex proximity extension assay and quantitative immunoassay.
Main Results:
- Colonic eosinophils were more abundant in both UC and PSC-UC compared to controls.
- Eosinophil activation markers were significantly increased in UC but not in PSC-UC.
- Pro-inflammatory cytokines were elevated in active UC but not in PSC-UC.
Conclusions:
- Eosinophil activation phenotype distinguishes UC from PSC-UC.
- This distinction may be influenced by the local cytokine profile in the colonic mucosa.
- Findings provide novel insights into the immune mechanisms underlying PSC-UC.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Primary Active Transport
Primary Active Transport
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.